The Cancer Institute Hospital of JFCR

Our Treatments｜Features of the Department｜Doctors and Staff

Our Treatments

The Department of Genitourinary Oncology is in charge of various tumors that develop in the urinary tract (kidney, renal pelvis, ureter, bladder and urethra), reproductive organs (prostate, seminal vesicles, penis and testis), adrenal gland and retroperitoneum.

Specifically, we make the diagnosis and treatment of the following cancers.

Renal cancer
We treat a small renal tumor with partial nephrectomy, and treat locally advanced or metastatic renal cell cancer with molecular targeted therapy and/or extended metastatectomy.
Bladder cancer
We treat non-muscle-invasive bladder cancer with transurethral resection (TUR), muscle invasive bladder cancer with radical cystectomy and urinary diversion or bladder preservation therapy, locally advanced bladder cancer with extended radical cystectomy following neoadjuvant chemotherapy, and metastatic bladder cancer with systemic chemotherapy.
Prostate cancer
We make a diagnosis based on the three-dimensional prostate biopsy. According to the stage of cancer, we provide the most suitable combination of treatments such as active surveillance, low-dose-rate brachytherapy, IMRT, robot-assisted or open radical prostatectomy, hormonal therapy and chemotherapy.
Testicular cancer
We treat stage I testicular cancer with orchiectomy and careful follow-up without additional therapy, advanced cancer with systemic chemotherapy and residual tumor resection, and recurrent cancer with salvage chemotherapy.

Features of the Department

We always try to provide the latest, the most appropriate, and safe treatment based on rapid and accurate diagnosis. We regularly hold the Cancer Board conference among specialists for diagnosis and treatment such as urologists, radiologists, chemotherapists, pathologists, pharmacists and nurses.

Rapidity

We make a proposal of an appropriate treatment plan within two weeks from the initial visit, making a definitive diagnosis of the cancer and confirming of the cancer’s stage.

Accurate Diagnosis

We aim to make an accurate diagnosis using the latest technology and knowledge such as diagnostic imaging (ultrasonography, CT, MRI, scintigraphy, PET), endoscopy and US- or CT-guided percutaneous needle biopsies. The Department of Pathology and the Department of Cytology with highly skilled doctors and technicians play an important role in diagnosis of cancer. We cooperate closely with these departments to improve the accuracy and rapidity of diagnosis. In particular, our 3-D prostate biopsy for prostate cancer is highly regarded not only in Japan but also around the world.

Comprehensive Diagnosis

We aim to provide team medical care in order to diagnose comprehensively and to determine appropriate treatment plan. To discuss the cases, we hold the Cancer Board conference among the multidisciplinary team consisting of urologists in charge, medical oncologists, radiologists, pathologists, pharmacists and nurses.

We have a system in which no biased medical care is provided by an individual physician in charge based on his/her own judgment.

Sufficient Explanation

We take sufficient time to explain about the disease and treatment plans including the disease name, its diagnosis, latest treatment options, possible clinical trials, and effects and risks of the treatment.

We start the treatment after both the patient and the family fully understand the explanation.

Provision of the Best Medical Care

We aim to provide top-level medical care by combining abundant experience, skills and knowledge of the physicians.

Safety

We always make every effort for the safety of the treatment. Before treatment, we perform enough exams on risks of the planned treatment. During the treatment, medical specialists provide treatment with sufficient care. In surgical therapy, a postoperative management based on the clinical path is conducted completely, realizing the high level of the safety.